The effect of sitagliptin or alogliptin on blood glucose levels and vascular endothelial function in type2 diabetes

Trial Profile

The effect of sitagliptin or alogliptin on blood glucose levels and vascular endothelial function in type2 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2015

At a glance

  • Drugs Alogliptin (Primary) ; Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SILVER
  • Most Recent Events

    • 04 Feb 2015 Status changed from active, no longer recruiting to completed according to University Hospital Medical Information Network - Japan record.
    • 04 Jul 2014 According to the University Hospital Medical Information Network - Japan record, status changed from recruiting to active, no longer recruiting.
    • 21 Jan 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top